These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. THE EFFECT OF SEROTONIN AND SEROTONIN ANTAGONISTS ON EXTERNAL PANCREATIC SECRETION IN DOGS. HUDOCK JJ; KHENTIGAN A; VANAMEE P; LAWRENCE W J Surg Res; 1963 Aug; 3():307-12. PubMed ID: 14051998 [No Abstract] [Full Text] [Related]
5. [On the inhibition of various rat paw edemas by serotonin antagonists]. VOGEL G; MAREK ML Arzneimittelforschung; 1961 Nov; 11():1051-4. PubMed ID: 13926418 [No Abstract] [Full Text] [Related]
6. The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid. SAVINI EC Br J Pharmacol Chemother; 1956 Sep; 11(3):313-7. PubMed ID: 13364207 [No Abstract] [Full Text] [Related]
7. [Serotonin-producing tumors. A case treated with serotonin antagonists]. JENSEN K Nord Med; 1963 May; 69():601-5. PubMed ID: 13957630 [No Abstract] [Full Text] [Related]
8. Serotonin as a mediator of reserpine action in brain. PLETSCHER A; SHORE PA; BRODIE BB J Pharmacol Exp Ther; 1956 Jan; 116(1):84-9. PubMed ID: 13296021 [No Abstract] [Full Text] [Related]
9. Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. SHORE PA; SILVER SL; BRODIE BB Science; 1955 Aug; 122(3163):284-5. PubMed ID: 13246633 [No Abstract] [Full Text] [Related]
11. Blockade by brom-lysergic-acid-diethylamide (BOL) of the potentiating action of serotonin and reserpine on hexobarbital hypnosis. SALMOIRAGHI GC; SOLLERO L; PAGE IH J Pharmacol Exp Ther; 1956 Jun; 117(2):166-8. PubMed ID: 13332558 [No Abstract] [Full Text] [Related]
12. Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. CERLETTI A; ROTHLIN E Nature; 1955 Oct; 176(4486):785-6. PubMed ID: 13265830 [No Abstract] [Full Text] [Related]
13. A SENSITIVE METHOD FOR ESTIMATION OF ERGOMETRINE, BASED UPON SEROTONIN ANTAGONISM ON ISOLATED RAT UTERUS. SUND RB Acta Pharmacol Toxicol (Copenh); 1963; 20():233-42. PubMed ID: 14131815 [No Abstract] [Full Text] [Related]
14. Antagonism by some ergot derivatives of 5-HT-induced vasoconstriction. Conolan S; Taylor DA Eur J Pharmacol; 1986 Apr; 123(2):299-302. PubMed ID: 3709667 [TBL] [Abstract][Full Text] [Related]
15. Characterization of ergot and non-ergot serotonin antagonists by prolactin and growth hormone profiles during wakefulness and sleep. Clarenbach P; Del Pozo E; Brownell J; Heredia E; Spiegel R; Cramer H Brain Res; 1980 Dec; 202(2):357-63. PubMed ID: 7437907 [TBL] [Abstract][Full Text] [Related]
16. Biotechnology and genetics of ergot alkaloids. Tudzynski P; Correia T; Keller U Appl Microbiol Biotechnol; 2001 Dec; 57(5-6):593-605. PubMed ID: 11778866 [TBL] [Abstract][Full Text] [Related]
17. Serotonin and serotoninergic agents affect proliferation of normal and transformed lymphoid cells. Smejkal-Jagar L; Boranić M Immunopharmacol Immunotoxicol; 1995 Feb; 17(1):151-62. PubMed ID: 7759768 [TBL] [Abstract][Full Text] [Related]
18. [Inhibition, with alkaloids, of the steroid-dependent enzyme induction in Pseudomonas testosteroni]. Maturová M; Beckmann H; Wacker A Z Naturforsch B; 1967 Jun; 22(6):621-6. PubMed ID: 4384350 [No Abstract] [Full Text] [Related]
19. The role of the central nervous system on the action of epinephrine and adrenolytic drugs. Thuránszky K Arch Int Pharmacodyn Ther; 1966 Jan; 159(1):53-60. PubMed ID: 5918767 [No Abstract] [Full Text] [Related]
20. Effects of some ergot alkaloids on dopamine receptors of molluscan smooth muscle. Ishii Y; Takayanagi I J Pharmacobiodyn; 1982 Sep; 5(9):748-50. PubMed ID: 7153848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]